Intestinal fat does not inhibit gastric function through a hormonal somatostatin mechanism in dogs

Kevin C K Lloyd, V. Maxwell, G. Ohning, J. H. Walsh

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In awake dogs with chronic gastric, duodenal, and jejunal fistulas, F(ab)1 fragments of somatostatin monoclonal antibody (mAb S607) were administered intravenously (IV) to test the hypothesis that intraintestinal lipid inhibits peptone-stimulated gastric acid secretion and emptying by a hormonal somatostatin mechanism. Plasma somatostatin was increased significantly by duodenal and jejunal perfusion with 20% lipid. Somatostatin administered IV caused dose-dependent inhibition of meal-stimulated gastric acid secretion and gastric emptying similar to that seen after intestinal perfusion with lipid. Administration of mAb S607 F(ab)1 fragments significantly reversed somatostatin (400 pmol · kg-1 · h-1, IV)-induced inhibition of peptonestimulated acid output and gastric emptying. Acid output inhibited by intraduodenal lipid was reversed partially after F(ab)1 administration, but the inhibitory effect of intrajejunal lipid was not altered. Inhibition of acid secretion by IV somatostatin and by intraintestinal fat was not caused by a decrease in circulating gastrin concentrations. Gastric emptying delayed by intraintestinal lipid was unaffected by antibody administration. Somatostatin does not appear to be a major hormonal mediator of intestinal fat-induced inhibition of gastric acid secretion or delayed gastric emptying in dogs.

Original languageEnglish (US)
Pages (from-to)1221-1228
Number of pages8
JournalGastroenterology
Volume103
Issue number4
StatePublished - 1992

Fingerprint

Somatostatin
Stomach
Gastric Emptying
Fats
Dogs
Lipids
Gastric Acid
Acids
Perfusion
Peptones
Gastrins
Fistula
Meals
Monoclonal Antibodies
Antibodies

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Intestinal fat does not inhibit gastric function through a hormonal somatostatin mechanism in dogs. / Lloyd, Kevin C K; Maxwell, V.; Ohning, G.; Walsh, J. H.

In: Gastroenterology, Vol. 103, No. 4, 1992, p. 1221-1228.

Research output: Contribution to journalArticle

Lloyd, Kevin C K ; Maxwell, V. ; Ohning, G. ; Walsh, J. H. / Intestinal fat does not inhibit gastric function through a hormonal somatostatin mechanism in dogs. In: Gastroenterology. 1992 ; Vol. 103, No. 4. pp. 1221-1228.
@article{a135994add924eeaa6e654d429390f9d,
title = "Intestinal fat does not inhibit gastric function through a hormonal somatostatin mechanism in dogs",
abstract = "In awake dogs with chronic gastric, duodenal, and jejunal fistulas, F(ab)1 fragments of somatostatin monoclonal antibody (mAb S607) were administered intravenously (IV) to test the hypothesis that intraintestinal lipid inhibits peptone-stimulated gastric acid secretion and emptying by a hormonal somatostatin mechanism. Plasma somatostatin was increased significantly by duodenal and jejunal perfusion with 20{\%} lipid. Somatostatin administered IV caused dose-dependent inhibition of meal-stimulated gastric acid secretion and gastric emptying similar to that seen after intestinal perfusion with lipid. Administration of mAb S607 F(ab)1 fragments significantly reversed somatostatin (400 pmol · kg-1 · h-1, IV)-induced inhibition of peptonestimulated acid output and gastric emptying. Acid output inhibited by intraduodenal lipid was reversed partially after F(ab)1 administration, but the inhibitory effect of intrajejunal lipid was not altered. Inhibition of acid secretion by IV somatostatin and by intraintestinal fat was not caused by a decrease in circulating gastrin concentrations. Gastric emptying delayed by intraintestinal lipid was unaffected by antibody administration. Somatostatin does not appear to be a major hormonal mediator of intestinal fat-induced inhibition of gastric acid secretion or delayed gastric emptying in dogs.",
author = "Lloyd, {Kevin C K} and V. Maxwell and G. Ohning and Walsh, {J. H.}",
year = "1992",
language = "English (US)",
volume = "103",
pages = "1221--1228",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Intestinal fat does not inhibit gastric function through a hormonal somatostatin mechanism in dogs

AU - Lloyd, Kevin C K

AU - Maxwell, V.

AU - Ohning, G.

AU - Walsh, J. H.

PY - 1992

Y1 - 1992

N2 - In awake dogs with chronic gastric, duodenal, and jejunal fistulas, F(ab)1 fragments of somatostatin monoclonal antibody (mAb S607) were administered intravenously (IV) to test the hypothesis that intraintestinal lipid inhibits peptone-stimulated gastric acid secretion and emptying by a hormonal somatostatin mechanism. Plasma somatostatin was increased significantly by duodenal and jejunal perfusion with 20% lipid. Somatostatin administered IV caused dose-dependent inhibition of meal-stimulated gastric acid secretion and gastric emptying similar to that seen after intestinal perfusion with lipid. Administration of mAb S607 F(ab)1 fragments significantly reversed somatostatin (400 pmol · kg-1 · h-1, IV)-induced inhibition of peptonestimulated acid output and gastric emptying. Acid output inhibited by intraduodenal lipid was reversed partially after F(ab)1 administration, but the inhibitory effect of intrajejunal lipid was not altered. Inhibition of acid secretion by IV somatostatin and by intraintestinal fat was not caused by a decrease in circulating gastrin concentrations. Gastric emptying delayed by intraintestinal lipid was unaffected by antibody administration. Somatostatin does not appear to be a major hormonal mediator of intestinal fat-induced inhibition of gastric acid secretion or delayed gastric emptying in dogs.

AB - In awake dogs with chronic gastric, duodenal, and jejunal fistulas, F(ab)1 fragments of somatostatin monoclonal antibody (mAb S607) were administered intravenously (IV) to test the hypothesis that intraintestinal lipid inhibits peptone-stimulated gastric acid secretion and emptying by a hormonal somatostatin mechanism. Plasma somatostatin was increased significantly by duodenal and jejunal perfusion with 20% lipid. Somatostatin administered IV caused dose-dependent inhibition of meal-stimulated gastric acid secretion and gastric emptying similar to that seen after intestinal perfusion with lipid. Administration of mAb S607 F(ab)1 fragments significantly reversed somatostatin (400 pmol · kg-1 · h-1, IV)-induced inhibition of peptonestimulated acid output and gastric emptying. Acid output inhibited by intraduodenal lipid was reversed partially after F(ab)1 administration, but the inhibitory effect of intrajejunal lipid was not altered. Inhibition of acid secretion by IV somatostatin and by intraintestinal fat was not caused by a decrease in circulating gastrin concentrations. Gastric emptying delayed by intraintestinal lipid was unaffected by antibody administration. Somatostatin does not appear to be a major hormonal mediator of intestinal fat-induced inhibition of gastric acid secretion or delayed gastric emptying in dogs.

UR - http://www.scopus.com/inward/record.url?scp=0026629773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026629773&partnerID=8YFLogxK

M3 - Article

C2 - 1356872

AN - SCOPUS:0026629773

VL - 103

SP - 1221

EP - 1228

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 4

ER -